题名 | Attenuation of Hyperlipidemia- and Diabetes-Induced Early-Stage Apoptosis and Late-Stage Renal Dysfunction via Administration of Fibroblast Growth Factor-21 Is Associated with Suppression of Renal Inflammation |
作者 | |
发表日期 | 2013-12-09 |
发表期刊 | PLOS ONE 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
其他关键词 | ACTIVATED PROTEIN-KINASE ; CHRONIC KIDNEY-DISEASE ; OXIDATIVE STRESS ; FATTY-ACIDS ; LIPID NEPHROTOXICITY ; METABOLIC SYNDROME ; SODIUM RETENTION ; DB/DB MICE ; KAPPA-B ; NEPHROPATHY |
摘要 | Background: Lipotoxicity is a key feature of the pathogenesis of diabetic kidney disease, and is attributed to excessive lipid accumulation (hyperlipidemia). Increasing evidence suggests that fibroblast growth factor (FGF) 21 has a crucial role in lipid metabolism under diabetic conditions. Objective: The present study investigated whether FGF21 can prevent hyperlipidemia- or diabetes-induced renal damage, and if so, the possible mechanism. Methods: Mice were injected with free fatty acids (FFAs, 10 mg/10 g body weight) or streptozotocin (150 mg/kg) to establish a lipotoxic model or type 1 diabetic model, respectively. Simultaneously the mice were treated with FGF21 (100 mu g/kg) for 10 or 80 days. The kidney weight-to-tibia length ratio and renal function were assessed. Systematic and renal lipid levels were detected by ELISA and Oil Red O staining. Renal apoptosis was examined by TUNEL assay. Inflammation, oxidative stress, and fibrosis were assessed by Western blot. Results: Acute FFA administration and chronic diabetes were associated with lower kidney-to-tibia length ratio, higher lipid levels, severe renal apoptosis and renal dysfunction. Obvious inflammation, oxidative stress and fibrosis also observed in the kidney of both mice models. Deletion of the fgf21 gene further enhanced the above pathological changes, which were significantly prevented by administration of exogenous FGF21. Conclusion: These results suggest that FFA administration and diabetes induced renal damage, which was further enhanced in FGF21 knock-out mice. Administration of FGF21 significantly prevented both FFA- and diabetes-induced renal damage partially by decreasing renal lipid accumulation and suppressing inflammation, oxidative stress, and fibrosis. |
资助项目 | National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81370917, 81000294]; Wenzhou Medical University [QTJ13005]; China-Canada Joint Health Research Initiative [81061120517]; Starting-Up Fund for Chinese-American Research Institute for Diabetic Complications from Wenzhou Medical University |
出版者 | PUBLIC LIBRARY SCIENCE |
出版地 | SAN FRANCISCO |
ISSN | 1932-6203 |
卷号 | 8期号:12页码:e82275. |
DOI | 10.1371/journal.pone.0082275 |
页数 | 11 |
WOS类目 | Multidisciplinary Sciences |
WOS研究方向 | Science & Technology - Other Topics |
WOS记录号 | WOS:000328705200069 |
收录类别 | SCIE ; PUBMED ; SCOPUS |
URL | 查看原文 |
PubMed ID | 24349242 |
PMC记录号 | PMC3857822 |
SCOPUSEID | 2-s2.0-84891947508 |
通讯作者地址 | [Cai, Lu]Chinese-American Research Institute for Diabetic Complications,Wenzhou Medical University,China |
Scopus学科分类 | Multidisciplinary |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/4308 |
专题 | 温州医科大学 药学院(分析测试中心) 其他_附属第三医院(瑞安市人民医院) |
通讯作者 | Cai, Lu |
作者单位 | 1.Chinese-American Research Institute for Diabetic Complications,Wenzhou Medical University,China; 2.Ruian Center of the Chinese-American Research Institute for Diabetic Complications,Third Affiliated Hospital,Wenzhou Medical University,China; 3.School of Pharmacy,Wenzhou Medical University,China; 4.Kosair Children's Hospital Research Institute,Department of Pediatrics,University of Louisville,United States |
第一作者单位 | 温州医科大学; 其他_附属第三医院(瑞安市人民医院) |
通讯作者单位 | 温州医科大学 |
第一作者的第一单位 | 温州医科大学 |
推荐引用方式 GB/T 7714 | Zhang, Chi,Shao, Minglong,Yang, Hong,et al. Attenuation of Hyperlipidemia- and Diabetes-Induced Early-Stage Apoptosis and Late-Stage Renal Dysfunction via Administration of Fibroblast Growth Factor-21 Is Associated with Suppression of Renal Inflammation[J]. PLOS ONE,2013,8(12):e82275.. |
APA | Zhang, Chi., Shao, Minglong., Yang, Hong., Chen, Liangmiao., Yu, Lechu., ... & Lu, Xuemian. (2013). Attenuation of Hyperlipidemia- and Diabetes-Induced Early-Stage Apoptosis and Late-Stage Renal Dysfunction via Administration of Fibroblast Growth Factor-21 Is Associated with Suppression of Renal Inflammation. PLOS ONE, 8(12), e82275.. |
MLA | Zhang, Chi,et al."Attenuation of Hyperlipidemia- and Diabetes-Induced Early-Stage Apoptosis and Late-Stage Renal Dysfunction via Administration of Fibroblast Growth Factor-21 Is Associated with Suppression of Renal Inflammation".PLOS ONE 8.12(2013):e82275.. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论